Compare two different usages of FRD for detecting high-grade cervical lesions and invasive cancer
- 41 Downloads
To evaluate two usages of the folate receptor-mediated staining solution (FRD) for detecting high-grade cervical lesions and invasive cancer, and compared with cytology test (TCT) and human papillomavirus (HPV) testing.
FRD sampling and FRD direct staining methods were used for detecting high-grade cervical lesions and invasive cancer. As a comparison, TCT and HPV testing were also applied for screening high-grade cervical lesions and invasive cancer. The sensitivity and specificity of TCT, HPV testing, and staining results of FRD were analyzed by the SPSS software.
In this study, 317 patients with biopsy were collected. The positive rate of FRD sampling method was 35.33% (112/317), and positive rate of FRD direct staining was 48.90% (155/317). Area under the curve (AUC) of TCT, HPV testing, FRD sampling and FRD direct staining were 0.53, 0.55, 0.58, and 0.75, respectively. The sensitivity of TCT, HPV, FRD sampling and FRD direct staining was 69.72%, 97.25%, 64.22% and 81.65%, respectively, and the specificity was 37.98%, 12.98%, 79.81% and 68.27%, respectively.
Compared with TCT and HPV testing, two usages of FRD methods have compatible sensitivity and high specificity to detect high-grade cervical lesions and invasive cancer. FRD direct staining may be comfortable for routine cervical cancer screening
KeywordsFolate receptor-mediated staining solution (FRD) High-grade cervical lesions Invasive cancer Cytology test Human papillomavirus testing
DHL: guarantor of integrity of the entire study, study concepts and design, definition of intellectual content, literature research, statistical data analysis, manuscript preparation, editing, and review. YPD: clinical studies and studies. LRW: clinical studies and data acquisition.
This study was not funded.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Organization WH (2005) IARC handbooks of cancer prevention, vol 10. Cervix cancer screening, pp 117–120.Google Scholar
- 5.Berkhof J, Meijer CJ (2007) Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med 358:642 (author reply 3) Google Scholar
- 9.Zhang CH, Xue XL, Dang RF, Gynecology DO (2014) Application value of folate receptor mediated FRD in diagnosis of cervical intraepithelial neoplasia and cancer. Chin J Lab Diagn 8:7830–7836Google Scholar
- 10.Lu MH, Hu LY, Du XX et al (2014) An special epithelial staining agents: folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer. Int J Clin Exp Med 8:7830Google Scholar
- 11.Anonymous (2010) The 1991 bethesda system for reporting cervical/vaginal cytological diagnoses. Diagn Cytopathol 9:235–246Google Scholar